ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,983,000 | -24.5% | 70,700 | 0.0% | 0.09% | -41.8% |
| Q3 2020 | $2,628,000 | -27.6% | 70,700 | 0.0% | 0.16% | -30.1% |
| Q2 2020 | $3,628,000 | +62.8% | 70,700 | 0.0% | 0.23% | +49.7% |
| Q1 2020 | $2,229,000 | -57.5% | 70,700 | -19.7% | 0.15% | -39.1% |
| Q4 2019 | $5,247,000 | +62.6% | 88,000 | 0.0% | 0.25% | +74.6% |
| Q3 2019 | $3,226,000 | -21.2% | 88,000 | 0.0% | 0.14% | -11.2% |
| Q2 2019 | $4,094,000 | +15.9% | 88,000 | 0.0% | 0.16% | +8.1% |
| Q1 2019 | $3,533,000 | -12.7% | 88,000 | 0.0% | 0.15% | -27.8% |
| Q4 2018 | $4,048,000 | -31.8% | 88,000 | -34.2% | 0.20% | -5.1% |
| Q3 2018 | $5,937,000 | +13.2% | 133,800 | 0.0% | 0.22% | +18.7% |
| Q2 2018 | $5,244,000 | -63.5% | 133,800 | -32.6% | 0.18% | -64.1% |
| Q1 2018 | $14,365,000 | -3.0% | 198,600 | -11.7% | 0.51% | +11.7% |
| Q4 2017 | $14,814,000 | +31.4% | 225,000 | 0.0% | 0.45% | -4.6% |
| Q3 2017 | $11,277,000 | +8.3% | 225,000 | 0.0% | 0.48% | +209.1% |
| Q2 2017 | $10,413,000 | +31.1% | 225,000 | 0.0% | 0.15% | +22.2% |
| Q1 2017 | $7,945,000 | +891.9% | 225,000 | +251.6% | 0.13% | +800.0% |
| Q4 2016 | $801,000 | -9.6% | 64,000 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $886,000 | -30.0% | 64,000 | -50.0% | 0.02% | -20.0% |
| Q2 2016 | $1,265,000 | +16.9% | 128,000 | +100.0% | 0.02% | +11.1% |
| Q1 2016 | $1,082,000 | -24.1% | 64,000 | 0.0% | 0.02% | -18.2% |
| Q4 2015 | $1,425,000 | -5.6% | 64,000 | 0.0% | 0.02% | -15.4% |
| Q3 2015 | $1,510,000 | -57.6% | 64,000 | +46.8% | 0.03% | -50.0% |
| Q2 2015 | $3,565,000 | – | 43,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |